Floatz logo

Equine Atg

Diamond-Blackfan Anemia

Masonic Cancer Center, University of MinnesotaPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Diamond-Blackfan Anemia cohort.

Asset / SponsorPhaseRating
Deferasirox
Novartis
Phase 4BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 2/3BBB
Busulphan
Paul Szabolcs
Phase 2/3BBB
Cyclophosphamide
Paul Szabolcs
Phase 2/3BB
Thiotepa
Fred Hutchinson Cancer Center
Phase 2BB

View all 24 →

Same molecule, other indications

Equine Atg is also rated in:

acute lymphoblastic leukemiaDormant
BBB
Indicative ·
72 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
68 / 100
View asset →
Hemoglobinuria, Paroxysmal Nocturnal (PNH)Dormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →